Twentyeight-Seven Therapeutics jobs and careers
About Twentyeight-Seven Therapeutics
Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.
Founded in 2016 by Frank Slack, George Daley, Piotr Sliz and Richard Gregory.
- Founded
- 2016
- Employees
- 11 to 50
- Total funding
- $80M
Jobs at Twentyeight-Seven Therapeutics
No open positions right now. Explore more companies on TheJobsMap.